tirzepatide side effects blindness Mounjaro (Tirzepatide) Effects: Your Month-by-Month Guide Weight-loss drugs like semaglutide and
Description
The FDA has approved Wegovy for chronic weight loss management to treat obesity and reduce the risk of certain cardiovascular events
In one trial, tirzepatide was shown to cause weight loss of up to 22% in people with a BMI of 30 or higher and at least one associated health problem
Adams, T
Contraindications against tirzepatide use include pregnancy and breastfeeding
Drucker DJ
This is the same reason why oral tirzepatide requires special formulation technology to survive adult GI digestion
